Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2177 (LINC02177) is a member of the long intergenic non-coding RNA family, defined as an autonomously transcribed RNA molecule longer than 200 nucleotides that does not overlap protein-coding genes[1][3][5]. LINC02177, like other lincRNAs, does not encode a protein and its functions are presumed to include regulation of gene expression, chromatin structure, and transcription, although its specific roles and biological significance remain unknown due to limited functional annotation. There is no current evidence establishing LINC02177 as a therapeutic target or as directly implicated in specific human diseases[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2177 (LINC02177).